The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Pulmonary Hypertension: A Brief Guide for Clinicians
Open accessAbstract
Pulmonary hypertension (PH) is classified into 5 clinical subgroups: pulmonary arterial hypertension (PAH), PH due to left-sided heart disease, PH due to chronic lung disease, chronic thromboembolic PH (CTEPH), and PH with an unclear and/or multifactorial mechanisms. A range of underlying conditions can lead to these disorders. Overall, PH affects approximately 1% of the global population, and over half of patients with heart failure may be affected. Cardiologists are therefore likely to encounter PH in their practice. Routine tests in patients with symptoms and physical findings suggestive of PH include electrocardiography, chest radiography, and pulmonary function tests. Transthoracic echocardiography is used to estimate the probability of PH. All patients with suspected or confirmed PH, without confirmed left-sided heart or lung diseases, should have a ventilation-perfusion scan to exclude CTEPH. Right-sided heart catheterization is essential for accurate diagnosis and classification. All patients with PAH or CTEPH must be referred to a specialist center. Surgical pulmonary endarterectomy is the treatment of choice for eligible patients with CTEPH. Targeted treatments (phosphodiesterase type 5 inhibitors, soluble guanylate cyclase stimulators, endothelin receptor antagonists, prostacyclin analogues, and prostacyclin receptor agonists) are licensed for patients with PAH. The soluble guanylate cyclase stimulator riociguat is the only licensed targeted therapy for patients with inoperable or persistent/recurrent CTEPH. Management of PH resulting from left-sided heart disease primarily involves treatment of the underlying condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghofrani, H.-A., Simonneau, G., D'Armini, A. M., Fedullo, P., Howard, L. S., Jaïs, X., Jenkins, D. P., Jing, Z.-C., Madani, M. M., Martin, N., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30305-3 · Cited by 264
RetractedAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Reddy, Y. N. V., Carter, R. E., Obokata, M., Redfield, M. M., & Borlaug, B. A. (2018) · Circulation · doi:10.1161/circulationaha.118.034646 · Cited by 1,278
Chronic Thromboembolic Pulmonary Hypertension
Hoeper, M. M., Mayer, E., Simonneau, G., & Rubin, L. J. (2006) · Circulation · doi:10.1161/circulationaha.105.602565 · Cited by 1,148
A global view of pulmonary hypertension
Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., Jing, Z.-C., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,039
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jais, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H.-A., & Jenkins, D. P. (2019) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,007
Risk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819
Pulmonary hypertension in chronic lung disease and hypoxia
Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01914-2018 · Cited by 757
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Boucly, A., Weatherald, J., Savale, L., Jaïs, X., Cottin, V., Prevot, G., Picard, F., de Groote, P., Jevnikar, M., Bergot, E., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00889-2017 · Cited by 697
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest · doi:10.1016/j.chest.2019.02.004 · Cited by 643
Vonk Noordegraaf, A., Chin, K. M., Haddad, F., Hassoun, P. M., Hemnes, A. R., Hopkins, S. R., Kawut, S. M., Langleben, D., Lumens, J., & Naeije, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01900-2018 · Cited by 569
Pulmonary hypertension due to left heart disease
Vachiéry, J.-L., Tedford, R. J., Rosenkranz, S., Palazzini, M., Lang, I., Guazzi, M., Coghlan, G., Chazova, I., & De Marco, T. (2019) · European Respiratory Journal · doi:10.1183/13993003.01897-2018 · Cited by 555
Kylhammar, D., Kjellström, B., Hjalmarsson, C., Jansson, K., Nisell, M., Söderberg, S., Wikström, G., & Rådegran, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx257 · Cited by 540
The endothelin system in pulmonary arterial hypertension
GALIE, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 515
Diagnosis of pulmonary hypertension
Frost, A., Badesch, D., Gibbs, J. S. R., Gopalan, D., Khanna, D., Manes, A., Oudiz, R., Satoh, T., Torres, F., & Torbicki, A. (2019) · European Respiratory Journal · doi:10.1183/13993003.01904-2018 · Cited by 479
Hoeper, M. M., & Granton, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0662ci · Cited by 316
Therapy for Pulmonary Arterial Hypertension in Adults
Klinger, J. R., Elliott, C. G., Levine, D. J., Bossone, E., Duvall, L., Fagan, K., Frantsve-Hawley, J., Kawut, S. M., Ryan, J. J., Rosenzweig, E. B., et al. (2019) · Chest · doi:10.1016/j.chest.2018.11.030 · Cited by 298
Hoeper, M. M., Benza, R. L., Corris, P., de Perrot, M., Fadel, E., Keogh, A. M., Kühn, C., Savale, L., & Klepetko, W. (2019) · European Respiratory Journal · doi:10.1183/13993003.01906-2018 · Cited by 216 · cited 1×
“Management of comorbidities (eg, sleep apnea and COPD) is essential in all patients with PH, and patients in any group may require supportive therapies such as diuretics, oxygen, and management of HF, including treatment of aggravating factors, optimization of fluid status, reduction of RV afterload, and cardiac inotr…”
BackgroundThe molecular targets of approved treatments for pulmonary arterial hypertension
Humbert, M. J. C., & Ghofrani, H. A. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207170 · Cited by 177
A Simple Echocardiographic Prediction Rule for Hemodynamics in Pulmonary Hypertension
Opotowsky, A. R., Ojeda, J., Rogers, F., Prasanna, V., Clair, M., Moko, L. E., Vaidya, A., Afilalo, J., & Forfia, P. R. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.976654 · Cited by 136
Self-citationTreatment strategies for the right heart in pulmonary hypertension
Westerhof, B. E., Saouti, N., van der Laarse, W. J., Westerhof, N., & Noordegraaf, A. V. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx148 · Cited by 80
Pulmonary Hypertension: Types and Treatments
Rose‐Jones, L. J., & McLaughlin, V. V. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x09666131117164122 · Cited by 75
Grapsa, J., Nunes, M. C. P., Tan, T. C., Cabrita, I. Z., Coulter, T., Smith, B., Dawson, D. M., Gibbs, J. S. R., & Nihoyannopoulos, P. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.002107 · Cited by 74
Rose, L., Prins, K. W., Archer, S. L., PRITZKER, M. R., Weir, Ε. K., Misialek, J. R., & Thenappan, T. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.09.011 · Cited by 74
Mazurek, J. A., Vaidya, A., Mathai, S. C., Roberts, J. D., & Forfia, P. R. (2017) · Pulmonary Circulation · doi:10.1177/2045893217694175 · Cited by 73
Self-citationChronic Thromboembolic Pulmonary Hypertension
Elwing, J., Vaidya, A., & Auger, W. R. (2018) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.04.018 · Cited by 27
Self-citationEchocardiographic evaluation of diastolic function in the setting of pulmonary hypertension
Agrawal, V., Byrd, B. F., & Brittain, E. L. (2019) · Pulmonary Circulation · doi:10.1177/2045894019826043 · Cited by 18
Adusumalli, S., & Mazurek, J. A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0368-2 · Cited by 15
Hirashiki, A., Kondo, T., & Murohara, T. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-1241 · Cited by 3
Cited by
The Role of Osteopontin in Respiratory Health and Disease
Barkas, G. I., & Kotsiou, O. S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081259 · Cited by 16
Metadata
- Authors
- Mandras, S. A., Mehta, H. S., & Vaidya, A.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 95
- Issue
- 9
- Pages
- 1978-1988
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W3081354116
- Cited by
- 271
- References
- 32
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.